SlideShare a Scribd company logo
MICROCAPSULE/ MICROSPHERES:- TYPES, PREPARATION & EVALUATION
PRODIPTA CHAKRABORTY
19HMPS06, M1
DEPARTMENT OF PHARMACEUTICS
HIMALAYAN PHARMACY INSTITUTE
Microparticles or microspheres are
defined as small, insoluble, free
flowing spherical particles consisting
of a polymer matrix and drug. and
sized from about 50 nm to about 2
mm. The term nanospheres is often
applied to the smaller spheres (sized
10 to 500 nm) to distinguish them
from larger microspheres.
 Microcapsule:
consisting of an encapsulated core
particle. Entrapped substance
completely surrounded by a distinct
capsule wall.
 Micromatrix:
Consisting of homogenous
dispersion of active ingredient in
particle. Microcapsule Micromatrix
 Bioadhesive microspheres
 Magnetic microspheres
 Floating microspheres
 Radioactive microspheres
 Polymeric microspheres
 Biodegradable polymeric
microspheres
 Synthetic polymeric microspheres
 Controlled release for longer
period of time (like 1-3 months).
 Frequency is reduced and hence
patient compliance is increased.
 Constant release and hence no
peaks and troughs in concentration
of drug.
 Low dose and hence toxic effect is
less.
 Targeting the tissue is possible.
 Other organ toxicity is less.
 No distribution through out the
body (no dilution effect)
 Intended mainly for parenteral
route which causes pain.
 Forms a depot in tissue or muscle
for longer period and hence may
produce pain when muscle
activities are done.
 Once administered, it is difficult to
take back the dose.
 Polymer may produce toxic
effects.
 High cost.
Polymers used in the Microsphere
preparation:
Synthetic Polymers :
Non-biodegradable –
 PMMA
 Acrolein
 Epoxy polymers
Biodegradable-
 Lactides and Glycolides copolymers
 Polyalkyl cyanoacrylates
 Polyanhydrides
 Natural Materials 
 Proteins
 Albumins
 Gelatin
 Collagen
 Carbohydrates
 Starch agarose
 Carrageenan
 Chitosan  Chemically modified
carbohydrates
 Poly(acryl)dextran
 Poly(acryl)starch
 Single Emulsion techniques
 Double emulsion techniques
Polymerization techniques:
Normal polymerization
Interfacial polymerization
 Coacervation phase separation
techniques
 Emulsification-solvent evaporation
method
 Spray drying and spray congealing
 Brace process
 ORAL DELIVERY
 PARENTERAL DELIVERY
 PARTICLE SIZE.
 PARTICLE SHAPE.
 DENSITY DETERMINATION.
 ISOELECTRIC POINT.
 CAPTURE EFFICIENCY.
 RELEASE STUDIES.
 ANGLE OF CONTACT.
 The prepared batches of microspheres were characterized for their micromeritic
properties (Particle size, angle of repose, bulk density, tapped density and Carrs
index) and encapsulation efficiency as per the standard procedures reported in
literatures.The in vitro dissolution of batch EC5 was carried out in 900 ml of pH 1.2
Buffer as the dissolution medium using USP Type II apparatus apparatus at 75 rpm.
The temperature was maintained at 37 ± 0.5°C. The dissolution was carried out for
24 hours. The sampling volume was 5 ml. The time points included were 10 mins to
2 hrs. The absorbance’s of the sample at different time intervals were carried out
using UV visible spectrophotometer (UV 1800, Shimadzu) at λmax of 242 nm. The
drug release was calculated using calibration curve subjected to various kinetic
models such as zero order and first order to study the mechanism of release of drug
from microspheres.
 MICROSPHERES IN VACCINE
DELIVERY. Eg ; Diphtheria toxoid ,
Tetanus toxoid.
 TARGETED DRUG DELIVERY. Eg ;
ocular, eye (cornea).etc
 CONTROLLED RELEASE. Eg ; GI
tumors, Bone tumors.
 CHEMOEMBOLIZATION.
 IMMUNO MICROSPHERES
Review: Radioactive Microspheres
for Medical Applications,
International journal of
Pharmaceutics 282 (2004) 1-
18,Review polymer microspheres
for controlled drug release.
https://pharmawiki.in/wp-
content/uploads/2014/01/Formula
tion-and-evaluation-of-
microspheres.pdf
N.K.Jain ,Controlled and novel drug
delivery edited by reprint 2007
pg.no.236-255.
Thank you

More Related Content

PPTX
Formulation building blocks chap 3
PPTX
Electrosomes preparation and application
PPTX
review of guidelines for herbal cosmetics by private bodies like cosmos with ...
PPTX
Design of Cosmeceutical product.pptx
PPTX
Cosmetic regulatory
PDF
Statistical modeling in pharmaceutical research and development.
PPTX
Perfume ingredients listed as allergens in EU regulation.pptx
PPTX
Nucleic acid based therapeutic drug delivery system
Formulation building blocks chap 3
Electrosomes preparation and application
review of guidelines for herbal cosmetics by private bodies like cosmos with ...
Design of Cosmeceutical product.pptx
Cosmetic regulatory
Statistical modeling in pharmaceutical research and development.
Perfume ingredients listed as allergens in EU regulation.pptx
Nucleic acid based therapeutic drug delivery system

What's hot (20)

PPTX
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
PPTX
sunprotection, sunscreen classification and regulatory aspects
PPTX
CONFIDENCE REGIONS AND CONCEPT OF NON LINEARITY
PPTX
Computer aided biopharmaceutical characterization
PPTX
Cosmetics biological aspects
PPTX
Design of cosmeceutical product : Sun protection
PPTX
INTRANASAL ROUTE DELIVERY SYSTEM
PPTX
COSMETICS REGULATORY
PPTX
ORAL HYGIENE PRODUCTS (DESIGN OF COSMECEUTICAL PRODUCTS)
PPTX
Modified release drug products
PPTX
Emollients rheological additives classification and application
PPTX
Formulation Building blocks: Building blocks for different product formulatio...
PPTX
Single shot vaccines Naveen Balaji
PPTX
Micro capsules or microspheres
PPTX
Review of guidelines for herbal cosmetics by COSMOS
PPTX
Computational modeling in drug disposition
PPTX
microspheres types , preparation and evaluation
PPTX
Targeted drug delivery system
PPTX
Contraversial ingredientts
PPTX
computer aided biopharmaceutical characterization :gastrointestinal absorptio...
sunprotection, sunscreen classification and regulatory aspects
CONFIDENCE REGIONS AND CONCEPT OF NON LINEARITY
Computer aided biopharmaceutical characterization
Cosmetics biological aspects
Design of cosmeceutical product : Sun protection
INTRANASAL ROUTE DELIVERY SYSTEM
COSMETICS REGULATORY
ORAL HYGIENE PRODUCTS (DESIGN OF COSMECEUTICAL PRODUCTS)
Modified release drug products
Emollients rheological additives classification and application
Formulation Building blocks: Building blocks for different product formulatio...
Single shot vaccines Naveen Balaji
Micro capsules or microspheres
Review of guidelines for herbal cosmetics by COSMOS
Computational modeling in drug disposition
microspheres types , preparation and evaluation
Targeted drug delivery system
Contraversial ingredientts
Ad

Similar to MICROCAPSULE/ MICROSPHERES:- TYPES, PREPARATION & EVALUATION (20)

PPTX
presentationofnanoparticles-220430074606.pptx
PPTX
Microspheres
PPTX
Microspheres and magnetic
PPTX
Drug Delivery Through Microspheres
PPTX
Microspheres
PPTX
MicrospheresPreparationandEvaluations.pptx
PPTX
Microspheres Preparation and Evaluations.pptx
PDF
Microspheres Preparation and Evaluations.pdf
PPTX
sterile product and formulation technology presentation
PPTX
Evaluation of microencapsulation
PPTX
Microencapsulation Unit 2 Novel Drug Delivery System
PPTX
Nanoparticulate drug delivery sysytem
PPTX
Nanoparticulate drug delivery sysytem
PDF
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
PPTX
Microspheres ppt
PPT
MANUFACTURING EQUIPMENTS,EVALUATION & STABILITY ASPECTS OF MICROCAPSULE
PPTX
Microspheres and microcapsules
PPTX
nanoparticulatedrugdeliverysysytemchatap-160529060436.pptx
PPTX
NANOPARTICULATE DRUG DELIVERY SYSTEM
PDF
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
presentationofnanoparticles-220430074606.pptx
Microspheres
Microspheres and magnetic
Drug Delivery Through Microspheres
Microspheres
MicrospheresPreparationandEvaluations.pptx
Microspheres Preparation and Evaluations.pptx
Microspheres Preparation and Evaluations.pdf
sterile product and formulation technology presentation
Evaluation of microencapsulation
Microencapsulation Unit 2 Novel Drug Delivery System
Nanoparticulate drug delivery sysytem
Nanoparticulate drug delivery sysytem
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
Microspheres ppt
MANUFACTURING EQUIPMENTS,EVALUATION & STABILITY ASPECTS OF MICROCAPSULE
Microspheres and microcapsules
nanoparticulatedrugdeliverysysytemchatap-160529060436.pptx
NANOPARTICULATE DRUG DELIVERY SYSTEM
nanoparticulatedrugdeliverysysytemchatap-160529060436.pdf
Ad

More from Prodipta Chakraborty (11)

PPTX
Current Developments in Prevention and Treatment of Candidiasis  
PPTX
Cosmetics Regulatory
PPTX
Total quality management
PPTX
Vaccine delivery systems
PPTX
Tumor targeting
PPTX
Targeted drug delivery system
PPTX
Roll of polymer in sustained release drug delivery
PPTX
Protein and peptide drug delivery system
PPTX
Emollient AND SURFACTANT
PPTX
Biological clock
PPTX
Microneedle in Transdermal drug delivery system
Current Developments in Prevention and Treatment of Candidiasis  
Cosmetics Regulatory
Total quality management
Vaccine delivery systems
Tumor targeting
Targeted drug delivery system
Roll of polymer in sustained release drug delivery
Protein and peptide drug delivery system
Emollient AND SURFACTANT
Biological clock
Microneedle in Transdermal drug delivery system

Recently uploaded (20)

PDF
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
PPTX
Effects of lipid metabolism 22 asfelagi.pptx
PDF
Copy of OB - Exam #2 Study Guide. pdf
PDF
TISSUE LECTURE (anatomy and physiology )
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PPTX
Post Op complications in general surgery
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPT
Infections Member of Royal College of Physicians.ppt
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PDF
Pharmaceutical Regulation -2024.pdf20205939
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPTX
Enteric duplication cyst, etiology and management
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
Effects of lipid metabolism 22 asfelagi.pptx
Copy of OB - Exam #2 Study Guide. pdf
TISSUE LECTURE (anatomy and physiology )
Introduction to Medical Microbiology for 400L Medical Students
Post Op complications in general surgery
OSCE Series Set 1 ( Questions & Answers ).pdf
Infections Member of Royal College of Physicians.ppt
The_EHRA_Book_of_Interventional Electrophysiology.pdf
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
Pharmaceutical Regulation -2024.pdf20205939
focused on the development and application of glycoHILIC, pepHILIC, and comm...
neurology Member of Royal College of Physicians (MRCP).ppt
Electrolyte Disturbance in Paediatric - Nitthi.pptx
CHEM421 - Biochemistry (Chapter 1 - Introduction)
Enteric duplication cyst, etiology and management
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PEADIATRICS NOTES.docx lecture notes for medical students

MICROCAPSULE/ MICROSPHERES:- TYPES, PREPARATION & EVALUATION

  • 1. MICROCAPSULE/ MICROSPHERES:- TYPES, PREPARATION & EVALUATION PRODIPTA CHAKRABORTY 19HMPS06, M1 DEPARTMENT OF PHARMACEUTICS HIMALAYAN PHARMACY INSTITUTE
  • 2. Microparticles or microspheres are defined as small, insoluble, free flowing spherical particles consisting of a polymer matrix and drug. and sized from about 50 nm to about 2 mm. The term nanospheres is often applied to the smaller spheres (sized 10 to 500 nm) to distinguish them from larger microspheres.
  • 3.  Microcapsule: consisting of an encapsulated core particle. Entrapped substance completely surrounded by a distinct capsule wall.  Micromatrix: Consisting of homogenous dispersion of active ingredient in particle. Microcapsule Micromatrix
  • 4.  Bioadhesive microspheres  Magnetic microspheres  Floating microspheres  Radioactive microspheres  Polymeric microspheres  Biodegradable polymeric microspheres  Synthetic polymeric microspheres
  • 5.  Controlled release for longer period of time (like 1-3 months).  Frequency is reduced and hence patient compliance is increased.  Constant release and hence no peaks and troughs in concentration of drug.  Low dose and hence toxic effect is less.  Targeting the tissue is possible.  Other organ toxicity is less.  No distribution through out the body (no dilution effect)
  • 6.  Intended mainly for parenteral route which causes pain.  Forms a depot in tissue or muscle for longer period and hence may produce pain when muscle activities are done.  Once administered, it is difficult to take back the dose.  Polymer may produce toxic effects.  High cost.
  • 7. Polymers used in the Microsphere preparation: Synthetic Polymers : Non-biodegradable –  PMMA  Acrolein  Epoxy polymers Biodegradable-  Lactides and Glycolides copolymers  Polyalkyl cyanoacrylates  Polyanhydrides
  • 8.  Natural Materials   Proteins  Albumins  Gelatin  Collagen  Carbohydrates  Starch agarose  Carrageenan  Chitosan  Chemically modified carbohydrates  Poly(acryl)dextran  Poly(acryl)starch
  • 9.  Single Emulsion techniques  Double emulsion techniques Polymerization techniques: Normal polymerization Interfacial polymerization  Coacervation phase separation techniques  Emulsification-solvent evaporation method  Spray drying and spray congealing  Brace process
  • 10.  ORAL DELIVERY  PARENTERAL DELIVERY
  • 11.  PARTICLE SIZE.  PARTICLE SHAPE.  DENSITY DETERMINATION.  ISOELECTRIC POINT.  CAPTURE EFFICIENCY.  RELEASE STUDIES.  ANGLE OF CONTACT.
  • 12.  The prepared batches of microspheres were characterized for their micromeritic properties (Particle size, angle of repose, bulk density, tapped density and Carrs index) and encapsulation efficiency as per the standard procedures reported in literatures.The in vitro dissolution of batch EC5 was carried out in 900 ml of pH 1.2 Buffer as the dissolution medium using USP Type II apparatus apparatus at 75 rpm. The temperature was maintained at 37 ± 0.5°C. The dissolution was carried out for 24 hours. The sampling volume was 5 ml. The time points included were 10 mins to 2 hrs. The absorbance’s of the sample at different time intervals were carried out using UV visible spectrophotometer (UV 1800, Shimadzu) at λmax of 242 nm. The drug release was calculated using calibration curve subjected to various kinetic models such as zero order and first order to study the mechanism of release of drug from microspheres.
  • 13.  MICROSPHERES IN VACCINE DELIVERY. Eg ; Diphtheria toxoid , Tetanus toxoid.  TARGETED DRUG DELIVERY. Eg ; ocular, eye (cornea).etc  CONTROLLED RELEASE. Eg ; GI tumors, Bone tumors.  CHEMOEMBOLIZATION.  IMMUNO MICROSPHERES
  • 14. Review: Radioactive Microspheres for Medical Applications, International journal of Pharmaceutics 282 (2004) 1- 18,Review polymer microspheres for controlled drug release. https://pharmawiki.in/wp- content/uploads/2014/01/Formula tion-and-evaluation-of- microspheres.pdf N.K.Jain ,Controlled and novel drug delivery edited by reprint 2007 pg.no.236-255.